In a wider perspective, the results of this study open up the possibilities for personalized medicine strategies for the treatment of prostate cancer, wherein prognostic and diagnostic tools could also incorporate genotypic study of PKCι genetic variations. Here, PRKCI is linked to Familial prostate cancer.